Analysis | The Health 202: Congress could have been tougher on drug executives

Drug industry executives testify before the Senate Finance Committee.

In the hearing on drug prices — billed as one of the biggest Congress-vs.-industry showdowns since the tobacco hearings of the 1990s — exchanges between the lawmakers and the CEOs were remarkably unremarkable. But while senators on the committee asked the executives a range of questions about the drug pipeline, thereThe witnesses frequently recited well-worn arguments for why insurers and pharmacy middlemen should share more of the blame for the high cos of prescription drugs. The senators largely refrained from insisting on direct answers as to why these companies have1. Drugmakers were reluctant to make firm commitments to lowering list prices even under their best-case scenario.

The executives expressed openness to the idea but stressed the rebate ban should apply broadly to drugs covered in commercial plans and not just government-run programs — and hinted that insurers should still feel a responsibility to charge smaller co-payments to customers.

This is just Congress giving the issue mouth service. Nothing will come of it.

Ya think ?!!!

That's for sure the republicans don't give a shit about us

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Analysis | The Health 202: States scramble to head off future Medicaid shortfallsStates like Oregon are imposing new taxes to make up the difference. Color me shocked, silly hippies This is what happens when you have a public option that only people who are statistically more likely to get sick/be sick are part of. If we expanded the public option by making it available to anyone who wants it then it would become a self-sustaining pool. They scramble to pay for Medicare yet easily approve $700B last year for war.
Source: washingtonpost - 🏆 95. / 72 Read more »

Analysis | The Health 202: HHS head Azar will take a victory lap on drug prices in speech todayThe Health 202: HHS head Azar will take a victory lap on drug prices in speech today Our great Governor DeSantis is doing this at the state level. Get on board wapo. this infuriating. They don't even understand how drug pricing works! They're supposed successes/proposals are nothing more than shifting costs from one bucket. That's to say nothing of the indirect (but no less severe) impact their idiocy will have on Medicare/Medicaid costs. Shameful
Source: washingtonpost - 🏆 95. / 72 Read more »